Patients are being asked to visit 'the most appropriate place' for treatment
A Greater Manchester hospital trust has issued a warning to patients with its A&E department under pressure. Bolton NHS Foundation Trust, which runs the Royal Bolton Hospital, told patients it was experiencing 'very high levels of activity' last night .
The trust moved to reassure people that the 'most seriously ill and injured patients' would be seen immediately. But other patients were being urged to find alternative places for care and treatment while the hospital deals with the strain. A spokesperson for Bolton NHS Foundation Trust said: "Our Emergency Department is currently experiencing very high levels of activity. No matter how busy our Emergency Department is, the most seriously ill and injured patients will always be seen immediately."If you choose to visit us and do not need urgent or emergency treatment, you will be safely supported to access an alternative service.
Hospitals across Greater Manchester issued a number of warnings over hectic emergency departments last autumn and winter, along with North West Ambulance Service. It came as the NHS battled a combination of the usual winter pressure, plus a backlog following the pandemic and industrial action.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasisThe color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.
Læs mere »
Targeted diet and exercise intervention could improve chemotherapy outcomes for breast cancer patientsA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer.
Læs mere »
Study provides new hope for patients with stage III EGFR-mutant non-small cell lung cancerThe immunotherapy drug, durvalumab, has been the standard of care for patients with stage III non-small cell lung cancer(NSCLC) to improve survival, when prescribed after chemotherapy and radiation therapy.
Læs mere »
Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patientsExtended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.
Læs mere »
Durvalumab shows tolerable surgical safety profile in patients with resectable NSCLCAdding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented today from the phase 3 AEGEAN trial at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.
Læs mere »
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancerA new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation greatly improves quality of life for patients with advanced prostate cancer, a phase III study finds.
Læs mere »